IKBKG and fibrosarcoma: Indeed, IP2 enhanced the presentation of the SL8 epitope in cancer cells expressing the globin-SL8-exon construct (Fig. 1b) and the endogenous nischarin-derived TL9 epitope in MCA205 fibrosarcoma.